Guangdong Hybribio Biotech (300639.SZ) shareholder Yunnan Zhonghe plans to reduce its stake by no more than 3%.
Cap Bio (300639.SZ) announced that the company's shareholder Yunnan Zhonghe Enterprise Management Co., Ltd. plans to reduce its holding of company shares by no more than 19.395 million shares (3% of the total share capital) through centralized bidding or block trading from March 6, 2026 to June 5, 2026.
Guangdong Hybribio Biotech (300639.SZ) announced that its shareholder Yunnan Zhonghe Enterprise Management Co., Ltd. plans to reduce its holdings of the company's shares by up to 19.395 million shares (3% of the total share capital) through centralized bidding or block trading from March 6, 2026, to June 5, 2026.
Related Articles

East China Engineering Science and Technology (002140.SZ) signed a strategic cooperation framework agreement with Qinghai Dongtai Jinai'er Lithium Resources Co., Ltd.

YIDU TECH (02158) eight consecutive repurchase transactions break ten million in a single day. Yesterday's repurchase amount has already ranked top three.

XUANWU CLOUD (02392) repurchased 4000 shares for 5721.72 Hong Kong dollars on February 4th.
East China Engineering Science and Technology (002140.SZ) signed a strategic cooperation framework agreement with Qinghai Dongtai Jinai'er Lithium Resources Co., Ltd.

YIDU TECH (02158) eight consecutive repurchase transactions break ten million in a single day. Yesterday's repurchase amount has already ranked top three.

XUANWU CLOUD (02392) repurchased 4000 shares for 5721.72 Hong Kong dollars on February 4th.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


